资讯

ICU Medical (Nasdaq: ICUI) announced today that it received FDA 510(k) clearance for several new additions to its infusion ...
San Clemente, California Wednesday, April 9, 2025, 11:00 Hrs [IST] ...
Needham analysts report that ICU Medical has a plan in place to handle its exposure to the tariffs imposed by the Trump ...
While CPOE and other technologies provide valuable safeguards, another layer of safety is needed to provide nurses with comparable safeguards with respect to i.v. drug infusion. Oral orders and ...
New devices address infusion delivery variability and expand the ICU Medical IV Performance Platform. Unlike traditional pumps that rely ... the delivery of their medications but also the infusion ...
regulatory clearance from the U.S. Food and Drug Administration (FDA) for the Plum Solo precision IV pump, a single-channel complement to the dual-channel Plum Duo. ICU Medical also received 510(k) ...
The Infusion Pump Market is valued at USD 14257.99 Million in 2022 and is expected to reach USD 27383.94 Million by 2030 at a ...
The infusion pumps market is experiencing significant growth due to the increasing demand for advanced healthcare solutions, particularly in the management of chronic diseases and critical care.
With these FDA clearances, ICU Medical is introducing its new category of precision IV pumps and expanding ... only the delivery of their medications but also the infusion data that supports ...
ICU Medical Inc. (NASDAQ:ICUI), a worldwide leader in the development, manufacture and sale of innovative medical devices, ...
ICU Medical (ICUI) has announced 510(k) regulatory clearance from the U.S. FDA for the Plum Solo precision IV pump, a single-channel complement ...